T1	Participants 101 123	advanced breast cancer
T2	Participants 180 202	advanced breast cancer
T3	Participants 473 562	Patients with newly diagnosed metastatic breast cancer or locally recurrent breast cancer
T4	Participants 1208 1219	49 patients
T5	Participants 739 784	The P600 (47 patients) and P900 (45 patients)
